89424-83-9

Usage

Uses

Used in Food Industry:
5-Isobenzofurancarboxaldehyde, 1,3-dihydro(9CI) is used as a flavoring agent for its sweet, floral scent, enhancing the taste and aroma of various food products.
Used in Perfume and Fragrance Industry:
This chemical compound is also utilized in the production of perfumes and fragrances due to its pleasant and distinctive odor, contributing to the creation of unique and appealing scents.
Used in Pharmaceutical Research:
5-Isobenzofurancarboxaldehyde, 1,3-dihydro(9CI) has been investigated for its potential biological and pharmacological activities. While more research is needed to fully understand its effects on the human body, it holds promise for future medicinal applications.

Upstream product

• 89424-84-0 5-hydroxymethyl-1,3-dihydroisobenzofuran 
• 188111-48-0 5-(bromomethyl)-1,3-dihydroisobenzofuran 
• 53957-33-8 2,5-dimethylbenzyl alcohol 
• 1310458-49-1 2,5-bis(bromomethyl)benzyl acetate 
• 1187196-72-0 1,3-dihydro-2-benzofuran-5-ylmethyl acetate 
• 22184-23-2 2,5-dimethylbenzyl acetate 
• 86-90-8 4-bromophthalic anhydride 
• 220513-49-5 5-bromo-1,3-dihydroisobenzofuran 
• 68-12-2 N,N-dimethyl-formamide 
• 171011-37-3 4-bromo-2-(hydroxymethyl)benzyl alcohol 

Downstream Products

• 90834-18-7 (E)-3-(1,3-Dihydro-isobenzofuran-5-yl)-1-(2-hydroxy-phenyl)-propenone 
• 89424-84-0 5-hydroxymethyl-1,3-dihydroisobenzofuran 
• 49571-72-4 [1-(1,3-Dihydro-isobenzofuran-5-yl)-meth-(E)-ylidene]-phenyl-amine 
• 2972-82-9 2-benzo[1,3]dioxol-5-ylmethylene-malononitrile 
• 1187196-40-2 5-(3,5-dichlorophenyl)-3-(1,3-dihydro-2-benzofuran-5-yl)-5-(trifluoromethyl)-4,5-dihydroisoxazole 
• 1448459-06-0 (Z)-3-(2-chlorophenyl)-5-((1,3-dihydroisobenzofuran-5-yl)methylene)-4-(4-(methylsulfonyl)phenyl)furan-2(5H)-one 
• 6974-47-6 (E)-3-(benzo[d][1,3]dioxol-6-yl)-2-methylacrylaldehyde 
• 598-02-7 Diethyl phosphate 
• 90834-17-6 (E)-3-(1,3-Dihydro-isobenzofuran-5-yl)-1-(2-hydroxy-5-methyl-phenyl)-propenone 

Relevant academic research and scientific papers

PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME

Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of, for example, pain.

SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME

Provided herein are spirocycle compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

PESTICIDAL CONDENSED - RING ARYL COMPOUNDS

Condensed-ring aryl compounds of formula (I) and use of the same as a agrochemical for controlling noxious organisms wherein (X)mQ, A, R1, (Y)n and the grouping -W1-W2-W3-W4- are as defined herein.

AZOLIDINONE-VINYL FUSED-BENZENE DERIVATIVES

The present invention is related to azolidinedione-vinyl fused-benzene derivatives of formula (I) for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, graft rejection or lung injuries. Formula (I), wherein A, X, Y, Z, R1 , R2 and n are as described in the description.

Samarium triiodide catalyzed deprotection of 1,1-diacetates

Catalyzed by samarium triiodide, cleavage of the 1,1-diacetates proceeds efficiently and selectively to give the corresponding aldehydes under neutral conditions.

1,3-Dioxan-5-ylalkenoic acids

The invention concerns novel 4-phenyl-1,3-dioxan-5-ylalkenoic acid derivatives of the formula I having cis relative stereochemistry at positions 4 and 5 of the dioxane ring and wherein Ra and Rb are variously hydrogen, alkyl, halogenoalkyl, alkenyl, and optionally substituted aryl or arylalkyl, Rc is hydroxy, alkoxy or alkanesulphonamido, n is 1 or 2, A is ethylene or vinylene, Y is (2-5C)polymethylene optionally substituted by alkyl, and benzene ring B is optionally substituted phenyl, or, when Rc is hydroxy, a salt thereof. The acid derivatives antagonize one or more of the actions of thromboxane A2 (TXA2) and are expected to be of value in those disease conditions in which TXA2 is involved. The invention also provides pharmaceutical compositions containing an acid derivative of formula I, and processes for their chemical production.